Arsenal Capital Partners Completes Acquisition of Cyalume Technologies

Posted on: September 18, 2017

NEW YORK, September 18, 2017 – Arsenal Capital Partners (“Arsenal”), a leading New York-based private
equity firm that invests in middle-market specialty industrials and healthcare companies, announced today
the acquisition of Cyalume Technologies (“Cyalume”), a leading specialty chemicals provider to diversified
end markets.

Cyalume produces specialty chemicals and pharmaceutical components, designs and manufactures
unique related products, and manufactures components for use in pharmaceutical, medical, commercial
and military markets. The company is headquartered in Ft. Lauderdale, FL and has manufacturing locations
in West Springfield, MA and Bound Brook, NJ as well as a subsidiary, Cyalume Technologies, SAS located
in Aix-en-Provence, France.

Zivi Nedivi, Cyalume’s President and CEO, commented, “We look forward to the partnership with Arsenal
to enhance our portfolio of technologies and operating capabilities. Cyalume participates in a number of
fragmented markets, such as specialty chemicals and pharmaceutical ingredients, and we expect to
capitalize on our position through a robust acquisition strategy.”

“We look forward to supporting the company’s organic and acquisition initiatives. Consistent with other
Arsenal investments, Cyalume will pursue a buy and build strategy in its core and adjacent markets while
continuing its focus on customers and innovation,” said Sal Gagliardo, Industry and Operations Partner at
Arsenal and Chairman of Cyalume.

Cyalume represents Arsenal’s second Specialty Industrials investment in 2017 following its acquisition of
PolyOne Corporation’s Designed Structures and Solutions business in July 2017.

About Arsenal Capital Partners
Established in 2000, Arsenal Capital Partners is a leading New York based private equity firm that
specializes in investments in middle market specialty industrials and healthcare companies. Since
inception, Arsenal has raised institutional equity investment funds of approximately $3 billion. Arsenal
invests in industry sectors in which the firm has significant prior knowledge and experience and seeks
companies typically in the range of $100 – $500 million of initial enterprise value. The firm works with
management teams to build strategically important companies with leading market positions, high growth,
and high value-add. For additional information on Arsenal Capital Partners, please visit
www.arsenalcapital.com.